Drawing for F-HISIEC

USPTO serial 79268325

F-HISIEC

Reviewed by CopyMark Law Group

Reg. 6010536Status 709
Filing date
Status date
Registration date
Mar 17, 2020
Examiner
LAVACHE, LINDA M
Law office
PUBLICATION AND ISSUE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with F-HISIEC?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Suzanne M. Hengl

Suzanne M. Hengl Baker Botts L.L.P.30 ROCKEFELLER PLAZA44th FloorNew York, NY 10112-4498

Goods and services

ClassDescriptionStatusFirst use
001Cells for scientific or research purposes, other than for medical or veterinary purposes; cell-derived preparations for scientific or research purposes; intestinal epithelial cells from human Induced Pluripotent Stem cells, used for scientific or research purposes for drug development; cellular tissue models, namely, biological tissue cultures containing human Induced Pluripotent Stem cells for measuring intestinal absorption efficiency, used for scientific or research purposes for drug development; cells, tissue models in the nature of biological tissue cultures, cell growth media, and biomaterials, all for use in biological, biomedical, and life sciences researchSECTION 71 - CANCELLED—
005Cells for medical use; cell preparations for the treatment of diseases or disorders, namely gastrointestinal diseases and disorders, toxicity, intestinal inflammation, intestinal wounds, fibrosis, and gastrointestinal tract infections; intestinal epithelial cells for medical purposes; intestinal epithelial cell preparations for the treatment of gastrointestinal diseases; pharmaceutical preparations to evaluate the toxicity, metabolism, drug absorption and compound efficacy of the small intestines; medicinal preparations to evaluate the toxicity, metabolism, drug absorption and compound efficacy of the small intestinesSECTION 71 - CANCELLED—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Oct 2, 2026C71TCANCELLED SECTION 71—
Mar 17, 2025REM3COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED—
Jan 28, 2023NREPNEW REPRESENTATIVE AT IB RECEIVED—
Aug 14, 2020FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Jul 29, 2020FICSFINAL DISPOSITION NOTICE SENT TO IB—
Jul 29, 2020FIMPFINAL DISPOSITION PROCESSED—
Jun 17, 2020FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Mar 17, 2020R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Jan 4, 2020GPNXNOTIFICATION PROCESSED BY IB—
Dec 31, 2019NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Dec 31, 2019PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Dec 18, 2019OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Dec 18, 2019OP2RNOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB—
Dec 11, 2019NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Nov 26, 2019CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Nov 23, 2019TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Nov 22, 2019CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Nov 22, 2019TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Nov 20, 2019ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Nov 20, 2019REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Nov 16, 2019RFNTREFUSAL PROCESSED BY IB—
Oct 31, 2019RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Oct 31, 2019RFRRREFUSAL PROCESSED BY MPU—
Oct 11, 2019RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Oct 10, 2019CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Oct 8, 2019MAFRAPPLICATION FILING RECEIPT MAILED—
Oct 4, 2019DOCKASSIGNED TO EXAMINER—
Oct 3, 2019NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Sep 27, 2019LIMILIMITATION FROM ORIGINAL APPLICATION ENTERED—
Sep 26, 2019REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance